American College of Cardiology – 2023 (New Orleans)

David Berg – GDF-15, Clinical Outcomes, and the Effect of Dapagliflozin in Patients with HFrEF: Insights from the DAPA-HF Trial.

David Berg – Prognostic Significance of Hemodynamic Parameters in Patients with Cardiogenic Shock

Brian Bergmark – Preclinical Evaluation of a Novel Solid Core Pressure Guidewire

Jason Feinman – Differences in Heart Failure-Related Cardiogenic Shock Between Ischemic and Non-Ischemic Cardiomyopathy: Data from The Critical Care Cardiology Network Registry

Nicholas Marston – Genetically Mediated Vascular Endothelial Cell Dysfunction and Its Dependence on Serum LDL-C Levels for the Development of Coronary Artery Atherosclerosis: Insights from the UK Biobank and FOURIER Trial

Filipe Moura – Genetic Predisposition To Adiposity Is Associated With Greater Risk Of Subsequent Heart Failure Events In Individuals With Type 2 Diabetes Mellitus

Filipe Moura – Risk Of Kidney Disease Progression And Efficacy Of SGLT2 Inhibition In Patients With Type 2 Diabetes Mellitus

Sabina Murphy – Reduction in Total CV Events with the PCSK9 Inhibitor Evolocumab in Patients with Cardiovascular Disease in the Combined FOURIER and FOURIER OLE Studies

Michelle O’Donoghue – Association of Baseline Lipoprotein(a) and Percentage of Lipoprotein(a) Lowering with Olpasiran

Siddharth Patel – NT-proBNP, Body Mass Index, and Heart Failure Risk in CAMELLIA-TIMI 61

Sarma Singam – Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights from The Critical Care Cardiology Trials Network

Andre Small – Relationship Between Cystatin C, Creatinine-Based eGFR, Cardiovascular Events and Kidney Outcomes in DECLARE-TIMI 58

Andre Zimerman – Edoxaban 30mg vs Warfarin in 2,406 Patients Age 80 or Greater: A Randomized Analysis from ENGAGE-TIMI 48

Andre Zimerman – Hepatic Fat Changes After An Antisense Oligonucleotide Therapy Targeting ANGPTL3: A TRANSLATE-TIMI 70 Analysis

%d bloggers like this: